Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Expert Review of Clinical Pharmacology|September 15, 2017
Microbiota-derived uremic retention solutes: perpetrators of altered nonrenal drug clearance in kidney diseaseAlexander J Prokopienko, Thomas D Nolin
International Journal of Nephrology|February 13, 2013
Endotoxin binding by sevelamer: potential impact on nutritional statusNatsuki Kubotera, Alexander J Prokopienko, Adinoyi O Garba, et al.
Journal of Pharmaceutical and Biomedical Analysis|July 6, 2019
Development and validation of a UHPLC-MS/MS method for measurement of a gut-derived uremic toxin panel in human serum: An application in patients with kidney diseaseAlexander J Prokopienko, Raymond E West, Jason R Stubbs, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 20, 2018
Decreased Kidney Function Is Associated with Enhanced Hepatic Flavin Monooxygenase Activity and Increased Circulating Trimethylamine <i>N</i>-Oxide Concentrations in MiceCassandra Johnson, Alexander J Prokopienko, Raymond E West, et al.
Frontiers in Medicine|November 21, 2018
Quantification of Lipoteichoic Acid in Hemodialysis Patients With Central Venous CathetersAmy Barton Pai, Adinoyi Garba, Paul Neumann, et al.
Journal of Clinical Pharmacology|September 12, 2024
Effect of Food on the Pharmacokinetics, Safety, and Tolerability of Budesonide Oral Suspension in Healthy Adult Participants: A Randomized Phase 1 StudyAlexander J Prokopienko, Junyao Wang, Vijay Yajnik, et al.
Plos One|November 21, 2012
Lipoteichoic acid from Staphylococcus aureus induces lung endothelial cell barrier dysfunction: role of reactive oxygen and nitrogen speciesAmy Barton Pai, Heena Patel, Alexander J Prokopienko, et al.
Preventing Chronic Disease|December 20, 2014
NSAID-avoidance education in community pharmacies for patients at high risk for acute kidney injury, upstate New York, 2011Soo Min Jang, Jennifer Cerulli, Darren W Grabe, et al.
Scientific Reports|November 6, 2019
Metabolic Activation of Flavin Monooxygenase-mediated Trimethylamine-N-Oxide Formation in Experimental Kidney DiseaseAlexander J Prokopienko, Raymond E West, Daniel P Schrum, et al.
Clinical Pharmacology and Therapeutics|May 23, 2023
A Quantitative Systems Pharmacology Model Describing the Cellular Kinetic-Pharmacodynamic Relationship for a Live Biotherapeutic Product to Support Microbiome Drug DevelopmentMarissa Renardy, Alexander J Prokopienko, Joseph R Maxwell, et al.
Pageof 2